夜间遗尿与隐性脊柱裂关系的前瞻性对照试验
该前瞻性对照研究纳入6至15岁夜遗尿患者184例与腹痛或侧腹痛对照180例,比较隐性脊柱裂(SBO)检出频率。
要点
- 合并SBO者干燥率及LUTS治疗反应率均显著低于无SBO者。
核心结论
- SBO在夜遗尿患者中比非夜遗尿患者更常见。
- 合并严重LUTS的SBO患者对夜遗尿治疗反应较低,可考虑更早采用进阶治疗。
研究设计与样本
- 前瞻性对照研究,纳入6至15岁因夜遗尿就诊于泌尿外科门诊的患者为夜遗尿组。
- 对照组为因腹痛或侧腹痛就诊的患者。
- 共纳入夜遗尿患者184例、对照患者180例。
- 伴LUTS的夜遗尿患者归为非单症状性夜遗尿(NMNE),单症状性夜遗尿患者接受去氨加压素治疗。
- NMNE患者若尿动力学检出膀胱过度活动或不抑制收缩,加用奥昔布宁治疗。
主要发现
- 共71例(19.5%)检出SBO,100例(27.4%)存在LUTS。
临床怎么用
- 对夜遗尿患者应关注是否合并SBO,尤其伴LUTS者。
- 对合并SBO且LUTS严重的夜遗尿患者,可考虑更早评估进阶治疗选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the frequency of spina bifida occulta (SBO) detected in patients with nocturnal enuresis (NE) and to investigate its clinical significance. METHODS: Patients aged 6 to 15 years who were admitted to the urology clinic with NE were included in this prospective study. The control group consisted of patients who were admitted with a complaint of abdominal or lateral pain. The patients who had lower urinary tract symptoms (LUTS) were classified as nonmonosymptomatic NE (NMNE). Those with monosymptomatic NE were treated with desmopressine. In patients with NMNE, treatment with oxybutynin was added if an overactive bladder or uninhibited contraction was detected by urodynamics. RESULTS: A total of 184 NE and 180 control patients were included in the study. SBO was detected in 71 (19.5%) patients and LUTS in 100 (27.4%). When the groups with and without NE were compared, the number of patients with SBO (26% vs 17%, P = .044) and those with LUTS (36% vs 17.5%, P < .001) were significantly higher in the NE group. The overall rate of dryness (67.4% vs 83.6%, P = .024) and response to LUTS treatment (65% vs 97%, P < .01) were significantly lower in those with SBO than in those without SBO. CONCLUSION: SBO is more common in NE patients than in non-NE patients. Response to NE treatment is lower in SBO patients with severe LUTS; for this population, advanced treatment options may be considered earlier.
引用
- Yavuz A, Bayar G, Kilinc MF, et al. The Relationship Between Nocturnal Enuresis and Spina Bifida Occulta: A Prospective Controlled Trial. Urology. 2018. PMID: 30099128. doi:10.1016/j.urology.2018.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。